GlaxoSmithKline shareholders await vote outcome

Anxious GlaxoSmithKline shareholders were tonight left waiting for news of the vote at today’s AGM at which many registered their dissent against a “golden parachute” package for chief executive Jean-Pierre Garnier.

The controversial deal caused a storm at the London meeting which featured one of the potentially biggest shareholder revolts in British corporate history.